RGLS-5040

N/A

Report date: 2025/07/02 16:42:58
NME

Base Information

Drug NameRGLS-5040
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA
Mechanisms of ActionRNA interferenceMicroRNAs inhibitors
TargetsMicroRNAs
Therapy Area/IndicationsCholestasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRegulus Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRegulus Therapeutics
Active IndicationsN/A
Inactive IndicationsCholestasis

Other Information

ATC CodeN/A
Related LinksN/A